123 North 86th Street
Wauwatosa, WI 53226
USA
(414) 774-0874
(414) 774-4837 Fax
Our web site contains information only and is not intended to create or solicit an attorney-client relationship. Although we welcome your questions and comments, contacting us from this web site does not create an attorney-client relationship. Information you may choose to disclose is not privileged or confidential. Nothing on our web site constitutes "legal advice." If you think you may need legal advice, we urge you to consult a lawyer to discuss your unique circumstances.
© 2002-2007 Gehrke & Associates, S.C.
« Honeywell Int'l Inc. v. Universal Avionics Sys. Corp. | Main | Monsanto Co. v. McFarling »
Bayer Aktiengesellschaft (Bayer) appeals the Trademark Trial and Appeal Board (Board) ruling that the proposed mark ASPIRINA is merely descriptive for analgesic goods. In re Bayer Aktiengesellschaft, Serial No. 78/212,751 (TTAB Mar. 17, 2006) (Final Decision). Because the Board’s ruling is supported by substantial evidence, we affirm.
